In the fight against allergy, science leads the way, and ALK has spent nearly a century pushing back the frontiers of knowledge with the aim of helping people to take control of their allergy and their life.
Our understanding of how allergy works has helped us to develop a range of allergy immunotherapy treatments, which form the core of our current product range.
Every year, we invest millions of euro in further research and development activities. Our current R&D focus is on completing and commercialising our portfolio of sublingual allergy immunotherapy (SLIT) tablets for the five most important allergens, and for all relevant ages.